ICG Enterprise Trust ICG Logo
Menu

Share price

1,066 p
8:16PM 1 Jul 2022

NAV per share

1761 p
As of 30 Apr 2022
Close
04 Oct 2018

Results for the six months to 31 July 2018

Profit growth and exit activity continues to drive strong performance

Highlights

  • NAV per share of 1,026p - total return of 8.1% in the six months
    • Well ahead of the FTSE-All Share, which returned 5.0%
  • Strong underlying profit growth and realisations at significant uplifts
    • 7.9% constant currency return on the investment Portfolio; 10.4% return in Sterling
    • 14% aggregate LTM1 earnings growth from largest 30 Companies; 47% of the portfolio
    • Realisations at 31% uplift; 2.3x multiple of cost
    • Highly cash generative Portfolio - £85m of proceeds received
  • Continued focus on deploying capital into highly defensive businesses
    • £76m of new investments made; 61% of capital deployed into high conviction assets of ICG funds, co-investments and secondary fund investments
    • Four co-investments and one secondary investment completed
    • High conviction investments now 44% of the Portfolio; weighted towards largest 30 Companies
  • Six new primary commitments
    • £102m of new commitments to six funds
    • Two new US relationships - The Jordan Company and Tailwind Capital
  • Strategic benefits of the scale and resources of ICG’s global platform continue to add significant value
    • £20m of co-investment alongside ICG; ICG managed investments represent 22% of the Portfolio
    • Proprietary opportunities sourced through the ICG network are proving to be particularly attractive
    • Portfolio more geographically diverse; US exposure 24% of the Portfolio
  • Portfolio well-positioned to continue to generate significant shareholder value
    • High quality Portfolio with strong underlying profit growth
    • Weighted towards companies that primarily have non-cyclical growth drivers
    • Attractive and well-balanced maturity; balancing near term realisation prospects and medium-longer term growth
  • Quarterly dividend of 5p per share
    • Total dividends for Q1 and Q2 of 10p per share
  • Continued short, medium and long-term outperformance of public markets
Performance to 31 July 2018 6 months 1 year 3 years 5 years  10 years2
Net asset value per share (total return) +8.1% +11.9% +55.4% +66.8% +126.4%
Share price (total return) +5.5% +17.3% +55.4% +97.3% +142.2%
FTSE All-Share Index (total return) +5.0% +9.2% +30.2% +44.9% +113.9%

1 Last 12 months.

2 As the Company changed its year end in 2010, the ten-year figures are for the 121-month period to 31 July 2018.

Emma Osborne, ICG, commented:

“The Portfolio continues to deliver, with underlying profit growth and realisation activity driving strong returns. As our managers continue to take advantage of the favourable environment to sell companies, we remain disciplined and selective when deploying capital, focusing on defensive companies in sectors with non-cyclical growth drivers, such as education and healthcare.

“We have a high quality Portfolio, a strong pipeline of opportunities and we believe the Portfolio is well-positioned to continue to generate significant shareholder value."

Download PDF (0.82Mb)
Shareprice Net Asset Value

Share price (ICGT)

1,066p
-14.00P (-1.30%)
8:16PM 1 Jul 2022
The share price information is delayed by at least 15 minutes
Share price information

NAV per share

1761p
As of 30 April 2022
Full year results for the twelve months ended 31 January 2022
NAV information
Year Net assets NAV per share Share price Dividends per share
Jan 2022 £1,158m 1,690p 1,200p 27p
Jan 2021 £952m 1,384p 966p 24p
Jan 2020 £794m 1,152p 966p 23p
Jan 2019 £731m 1,057p 822p 22p
Jan 2018 £664m 959p 818p 21p
Jan 2017 £613m 871p 698p 20p
Jan 2016 £521m 731p 545p 11p
Jan 2015 £507m 695p 575p 15.5p
Jan 2014 £494m 677p 563p 15.5p
Jan 2013 £460m 631p 487p 5p
Jan 2012 £415m 569p 357p 5p
Jan 2011 £389m 534p 308p 2.25p
Dec 2009 £338m 464p 305p 2.25p
Dec 2008 £327m 449p 187p 4.5p

Disclaimer

The information contained herein and on the pages that follow does not constitute an offer to sell, or the solicitation of an offer to acquire or subscribe for, any securities in any jurisdiction where such an offer or solicitation is unlawful or would impose any unfulfilled registration, qualification, publication or approval requirements on ICG Enterprise Trust PLC (the "Company") or its affiliates or agents. Equity securities in the Company have not been and will not be registered under the applicable securities laws of the United States, Australia, Canada, Japan or South Africa (each an “Excluded Jurisdiction”). The equity securities in the Company referred to herein and on the pages that follow may not be offered or sold within an Excluded Jurisdiction, or to any U.S. person ("U.S. Person") as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or to any national, resident or citizen of an Excluded Jurisdiction.

The promotion of the Company and the distribution of this website and the materials contained by it in the United Kingdom are restricted by law. Accordingly, this website and any materials contained by it should only be accessed by, and are directed only at:
(i) persons outside the United Kingdom to whom it is lawful to communicate to; or
(ii) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”); or
(iii) high net worth companies, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order, provided that in each case the website and any materials in are only directed at persons who are "qualified investors" as defined in article 2(1)(e) of Directive 2003/71/EC (as amended) (the "Prospectus Directive") ("Relevant Persons"). Accordingly, this website does not constitute, and does not contain the information required to be contained in, a prospectus as required under the Prospectus Directive.

This website is communicated by ICG Alternative Investment Limited (“ICG AIL”), which is authorised and regulated by the UK Financial Conduct Authority. In communicating this website ICG AIL is acting for the Company and is not responsible for advising persons viewing this website or any other person, or for providing them with the protections which would be given to those who are clients of ICG AIL under the rules of the FCA.
The information on the pages that follow may contain forward looking statements. Any statement other than a statement of historical fact is a forward looking statement. Actual results may differ materially from those expressed or implied by any forward looking statement. The Company does not undertake any obligation to update or revise any forward looking statements. You should not place undue reliance on any forward looking statement, which speaks only as of the date of its issuance.

Your access to this website is governed by the above terms. The Company may change these terms. The changes will be posted on the website. Your access to this website is governed by the version of these terms then in force.

By clicking "I understand and agree" below, you represent, warrant and agree that you (1) have read and understood these terms and the other information set out above, (2) agree to be bound by the terms, (3) do not have a registered address in, and are not resident or located in, an Excluded Jurisdiction (or, if you do, you will not seek to make any investment in the securities of the Company), (4) are not a U.S. Person or a national, resident or citizen of an Excluded Jurisdiction (or, if you are, you will not seek to make any investment in the securities of the Company), (5) are permitted under applicable laws and regulations to receive the information contained in the pages that follow, and (6) agree that you will not transmit or otherwise send any information contained in this website to any person in the United States or to any U.S. Person for the purpose of that person considering an investment in the securities of the Company, or to any publication with a general circulation in the United States.
If you cannot so certify and agree, you must click the button labelled "I decline" or otherwise exit this website.

I understand and agree

I decline